share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs John C

Novavax | 4: Statement of changes in beneficial ownership of securities

諾瓦瓦克斯醫藥 | 4：持股變動聲明
SEC announcement ·  03/27 06:15
牛牛AI助理已提取核心訊息
John C Jacobs, President and CEO of Novavax Inc. (NVAX), was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Jacobs after the action.
John C Jacobs, President and CEO of Novavax Inc. (NVAX), was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Jacobs after the action.
據報道，諾瓦瓦克斯公司（NVAX）總裁兼首席執行官約翰·雅各布斯於2024年3月1日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。該報告沒有提供有關雅各布斯在行動後持有的股票數量的信息。
據報道，諾瓦瓦克斯公司（NVAX）總裁兼首席執行官約翰·雅各布斯於2024年3月1日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。該報告沒有提供有關雅各布斯在行動後持有的股票數量的信息。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。